Use this document to submit brand price change for drugs listed on the Yukon Drug Formulary. View the Yukon Drug Formulary.
Documents
Displaying 9701 - 9707 of 9707
81-106 National Instrument, Investment Fund Continuous Disclosure, Securities Act, Amendment Effective March 3, 2025.
81-101 National Instrument, Mutual Fund Prospectus Disclosure, Amendment Effective March 3, 2025.
41-101 National Instrument, General Prospectus Requirements, Amendment Effective March 3, 2025.